These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36820954)

  • 1. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
    Li W; Huang G; Wei J; Cao H; Jiang G
    Mol Cell Biochem; 2023 Apr; 478(4):729-741. PubMed ID: 36070054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF2BP3 suppresses ferroptosis in lung adenocarcinoma by m6A-dependent regulation of TFAP2A to transcriptionally activate SLC7A11/GPX4.
    Li P; Chu D; Ding G; Qin D; Bu Y; Tian B
    Mol Cell Biochem; 2024 Jul; ():. PubMed ID: 39026029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
    Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
    Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer.
    Wang F; Sun Z; Zhang Q; Yang H; Yang G; Yang Q; Zhu Y; Wu W; Xu W; Wu X
    Chin Med; 2023 Sep; 18(1):122. PubMed ID: 37735401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation.
    Fan X; Wei C; Han Y
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner.
    Tang Z; Huang X; Mei H; Zheng Z
    J Bioenerg Biomembr; 2024 Apr; 56(2):149-157. PubMed ID: 38319402
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhao X; Zhao Z; Xie H; Gao W; Ye C
    Discov Med; 2024 Jan; 36(180):61-70. PubMed ID: 38273746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High expression of fragile X mental retardation protein inhibits ferroptosis of colorectal tumor cells by activating the RAS/MAPK signaling pathway].
    Wang N; Shi B; Man X; Wu W; Cao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):885-893. PubMed ID: 38862446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation.
    Shao Y; Liu Z; Song X; Sun R; Zhou Y; Zhang D; Sun H; Huang J; Wu C; Gu W; Zheng X; Jiang J
    Clin Transl Med; 2023 Jul; 13(7):e1318. PubMed ID: 37381158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis.
    Ming T; Lei J; Peng Y; Wang M; Liang Y; Tang S; Tao Q; Wang M; Tang X; He Z; Liu X; Xu H
    Phytother Res; 2024 Jun; ():. PubMed ID: 38837315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8
    Ge J; Liu SL; Zheng JX; Shi Y; Shao Y; Duan YJ; Huang R; Yang LJ; Yang T
    Transl Oncol; 2023 Aug; 34():101683. PubMed ID: 37224767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
    Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
    Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antitumor mechanism of triptonide in colorectal cancer: inducing ferroptosis via the SLC7A11/GPX4 axis.
    Wang W; Zhao X; Zhou J; Li H
    Funct Integr Genomics; 2024 Jul; 24(4):126. PubMed ID: 39012393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.